Cargando…

Additive Effect of Brinzolamide on Diurnal Changes in Intraocular Pressure in Latanoprost-treated Eyes

To investigate the effect of brinzolamide on diurnal fluctuations in the intraocular pressure (IOP) in patients on latanoprost ophthalmic solution prospectively was aimed. Eleven patients with primary open angle glaucoma were enrolled in this study. The subjects were admitted to the hospital and had...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abe, Keitetsu, Kashiwagi, Kenji
Formato:	Texto
Lenguaje:	English
Publicado:	Bentham Open 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699844/ https://www.ncbi.nlm.nih.gov/pubmed/19547665 http://dx.doi.org/10.2174/1874364100802010160

Ejemplares similares

Efficacy and Safety of Switching Latanoprost Monotherapy to Bimatoprost Monotherapy or Combination of Brinzolamide and Latanoprost
por: Imasawa, Mitsuhiro, et al.
Publicado: (2016)

24-hour intraocular pressure in glaucoma patients randomized to receive dorzolamide or brinzolamide in combination with latanoprost
por: Nakamura, Yoshimi, et al.
Publicado: (2009)

Effects of brinzolamide vs timolol as an adjunctive medication to latanoprost on circadian intraocular pressure control in primary open-angle glaucoma Japanese patients
por: Ishikawa, Makoto, et al.
Publicado: (2009)

Predictors of additional intraocular pressure reduction in patients changed to latanoprost/timolol fixed combination
por: Sellem, Eric, et al.
Publicado: (2010)

Diurnal Intraocular Pressure with Bimatoprost/Timolol Fixed Combination versus Latanoprost/Timolol Fixed Combination in Healthy Subjects
por: Shim, Seong Hee, et al.
Publicado: (2014)

Diurnal Intraocular Pressure Fluctuation in Eyes with Angle-closure
por: Bhartiya, Shibal, et al.
Publicado: (2015)

Effect of latanoprost on intraocular pressure, visual acuity and C-reactive protein
por: Hou, Ping, et al.
Publicado: (2020)

Peripheral Latanoprost Administration Lowers Intraocular Pressure in the Wistar Rat
por: Świątkiewicz, Maciej, et al.
Publicado: (2020)

Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case–control study
por: Song, Shuang, et al.
Publicado: (2016)

Comparison of Netarsudil/Latanoprost Therapy with Latanoprost Monotherapy for Lowering Intraocular Pressure: A Systematic Review and Meta-analysis
por: Lee, Jong-Wook, et al.
Publicado: (2022)

Intraocular Pressure-Lowering Effect of Latanoprost Is Hampered by Defective Cervical Lymphatic Drainage
por: Kim, Young Kook, et al.
Publicado: (2017)

Effects of Topical Latanoprost on Intraocular Pressure and Myopia Progression in Young Guinea Pigs
por: El-Nimri, Nevin W., et al.
Publicado: (2018)

Diurnal variation of central corneal thickness and intraocular pressure in eyes with pseudoexfoliation
por: Syed, Zeeshan, et al.
Publicado: (2019)

Effects of unoprostone on diurnal variation of intraocular pressure in healthy volunteers
por: Inoue, Kenji, et al.
Publicado: (2011)

Tear biomarkers in latanoprost and bimatoprost treated eyes
por: Reddy, Shweta, et al.
Publicado: (2018)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
por: Wang, Ningli, et al.
Publicado: (2020)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Nakakura, Shunsuke, et al.
Publicado: (2012)

Repeated Measurements Are Necessary for Evaluating Accurate Diurnal Rhythm Using a Self-Intraocular Pressure Measurement Device
por: Shigemoto, Yumi, et al.
Publicado: (2023)

The Influence of a Vitrectomy on the Diurnal Intraocular Pressure
por: Lee, Yong Woo, et al.
Publicado: (2015)

Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study
por: Takemoto, Daisuke, et al.
Publicado: (2017)

Diurnal variation in central corneal thickness and intraocular pressure in eyes with pseudoexfoliation syndrome without glaucoma
por: Keel, Stuart, et al.
Publicado: (2014)

Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review
por: Russo, Andrea, et al.
Publicado: (2008)

Mirtogenol(®) potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects
por: Steigerwalt, Robert D, et al.
Publicado: (2010)

Intraocular Pressure Reduction Effect of 0.005% Latanoprost Eye Drops in a Hyaluronic Acid-Chitosan Nanoparticle Drug Delivery System in Albino Rabbits
por: Rubenicia, Ana Marie L., et al.
Publicado: (2021)

Effect of a Topical Combination of Latanoprost and Pranoprofen on Intraocular Pressure and the Ocular Surface in Open-Angle Glaucoma Patients
por: Zhu, Simin, et al.
Publicado: (2018)

Pseudoexfoliation syndrome: Effect of phacoemulsification on intraocular pressure and its diurnal variation
por: Vahedian, Zakieh, et al.
Publicado: (2015)

Effect on Intraocular Pressure of Switching from Latanoprost and Travoprost Monotherapy to Timolol Fixed Combinations in Patients with Normal-Tension Glaucoma
por: Igarashi, Ryoko, et al.
Publicado: (2014)

Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure–Lowering Effects of Latanoprost
por: Roddy, Gavin W., et al.
Publicado: (2017)

Severe Cutaneous Reaction to Latanoprost Eye Drops
por: Yip, Ivan Yeu Ming, et al.
Publicado: (2018)

Longitudinal stability of the diurnal rhythm of intraocular pressure in subjects with healthy eyes, ocular hypertension and pigment dispersion syndrome
por: Huchzermeyer, Cord, et al.
Publicado: (2014)

Role of fixed-combination brinzolamide 1%/timolol 0.5% in the treatment of elevated intraocular pressure in open-angle glaucoma and ocular hypertension
por: Beckers, Henny JM, et al.
Publicado: (2009)

Comparison study of intraocular pressure reduction efficacy and safety between latanoprost and tafluprost in Japanese with normal-tension glaucoma
por: Ikeda, Yoko, et al.
Publicado: (2016)

Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure
por: Miller, Sally, et al.
Publicado: (2016)

Long-term Reliability of Diurnal Intraocular Pressure Patterns in Healthy Asians
por: Chun, Yeoun Sook, et al.
Publicado: (2017)

The Effect of Change in Intraocular Pressure on Choroidal Structure in Glaucomatous Eyes
por: Zhang, Xuemin, et al.
Publicado: (2017)

Additive effects of genetic variants associated with intraocular pressure in primary open-angle glaucoma
por: Mabuchi, Fumihiko, et al.
Publicado: (2017)

The effects of topical dorzolamide 2% and brinzolamide 1%, either alone or combined with timolol 0.5%, on intraocular pressure, pupil diameter, and heart rate in healthy cats
por: Slenter, Inge J. M., et al.
Publicado: (2019)

Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
por: Gandolfi, Stefano A., et al.
Publicado: (2014)

Effect of benzalkonium chloride–free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study
por: Lopes, Joao F., et al.
Publicado: (2015)

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
por: Onoe, Hiromitsu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_75p2jqj4dhtmrjgp22febqr784